Abstract
Aims of this study were to verify whether reduction in transplant-related mortality (TRM) of children with acute lymphoblastic leukemia (ALL) in second complete remission (CR) given allogeneic hematopoietic stem cell transplantation (HSCT) from unrelated volunteers has occurred over time and to investigate the role of other variables on the probabilities of relapse, TRM and event-free survival (EFS). We compared results obtained in 26 children given HSCT before January 1998 with those of 37 patients transplanted beyond that date. In all donor–recipient pairs, histocompatibility was determined by serology for HLA-A and -B antigens and by high-resolution DNA typing for DRB1 antigen. High-resolution molecular typing of HLA class I antigens was employed in 20 of the 37 children transplanted more recently. Probability of both acute and chronic GVHD was comparable in the two groups of patients. In multivariate analysis, children transplanted before January 1998, those with T-lineage ALL and those experiencing grade II–IV acute GVHD had a higher relative risk of TRM at 6 months after transplantation. Relapse rate was unfavorably affected by a time interval between diagnosis and relapse <30 months. The 2-year probability of EFS for children transplanted before and after 1 January 1998 was 27% (10–44) and 58% (42–75), respectively (P = 0.02), this difference remaining significant in multivariate analysis. EFS of unrelated donor HSCT in children with ALL in second CR has improved in the last few years, mainly due to a decreased TRM. This information is of value for counseling of patients with relapsed ALL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Henslee-Downey PJ, Gluckman E . Allogeneic transplantation from donors other than HLA-identical siblings Hematol/Oncol Clin North Am 1999 13: 1017–1039
Uderzo C, Rondelli R, Dini G, Dallorso S, Messina C, Miniero R, Locatelli F, De Manzini A, Pession A, Balduzzi A, Locasciulli A, Masera G . High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: a 7-year Italian multicentre study Br J Haematol 1995 89: 790–797
Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, Cesaro S, Porta F, Mazzarino I, Giorgiani G, Rondelli R, Locatelli F . Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings J Clin Oncol 1999 17: 1838–1846
Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, Di Girolamo G, Dini G, Miniero R, Locatelli F, Colella R, Tamaro P, Lo Curto M, Di Tullio MT, Masera G . Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association J Clin Oncol 1995 13: 352–358
Barrett AJ, Horowitz MM, Pollock B, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rimm AA, Klein JP, Shuster JJ, Sobocinsky KA, Gale RP . Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission N Engl J Med 1994 331: 1253–1258
Schroeder H, Gustafsson G, Saarinen-Pihkala UM, Glomstein A, Jonmundsson G, Nysom K, Ringden O, Mellander L . Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries Bone Marrow Transplant 1999 23: 555–560
Green A, Clarke E, Hunt L, Canterbury A, Lankester A, Hale G, Waldmann H, Goodman S, Cornish JM, Marks DI, Steward CG, Oakhill A, Pamphilon DH . Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome Blood 1999 94: 2236–2246
Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R . Unrelated donor marrow transplantation in children Blood 1995 86: 3247–3256
Davies SM, Wagner JE, Shu XO, Blazar BR, Katsanis E, Orchard PJ, Kersey JH, Dusenbery KE, Weisdorf DJ, McGlave PB, Ramsay NK . Unrelated donor bone marrow transplantation for children with acute leukemia J Clin Oncol 1997 15: 557–565
Souillet G, Rey S, Bertrand Y, Pujol M, Pondarre C, Bourgeot JP, Raba M, Eljaafari A, Chapuis F, Manel AM, Philippe N, Gebuhrer L . Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation Bone Marrow Transplant 2000 26: 31–43
Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C . Transplantation of marrow from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose Blood 1997 89: 4226–4235
Casper J, Camitta B, Truitt R, Baxter Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F . Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia Blood 1995 85: 2354–2363
Dini G, Lanino E, Lamparelli T, Barbanti M, Sacchi N, Carcassi C, Locatelli F, Porta F, Rosti G, Alessandrino EP, Aversa F, Marengo P, Guidi S, Uderzo C, Amoroso A, Di Bartolomeo P, Garbarono L, La Nasa G, Rossetti F, Miniero R, Soligo D, Manfredini L, Bacigalupo A . Unrelated donor marrow transplantation initial experience of the Italian bone marrow transplant group (GITMO) Bone Marrow Transplant 1996 17: 55–62
Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, Yoshida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku F . Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor N Engl J Med 1998 339: 1177–1193
Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, Woolfrey AE, Hansen JA . Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient Blood 1998 92: 3515–3520
Paolucci G, Vecchi V, Favre C, Miniero R, Madon E, Pession A, Rondelli R, De Rossi G, Lo Nigro L, Porta F, Santoro N, Indolfi P, Basso G, Conter V, Aricó M . Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study Haematologica 2001 86: 478–484
Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Coltella R, Basso G . Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica J Clin Oncol 1995 13: 2497–2502
Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G . Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study Haematologica 1998 83: 791–799
Conter V, Aricò M, Valsecchi MG, Basso G, Biondi A, Madon E, Mandelli F, Paolucci G, Pession A, Rizzari C, Rondelli R, Zanesco L, Masera G . Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982–1995 Leukemia 2000 14: 2196–2204
Locatelli F, Percivalle E, Comoli P, Maccario R, Zecca M, Georgiani G, De Stefano P, Gerna G . Human cytomegalovirus infection in pediatric patients given allogeneic bone marrow transplantation: role of early treatment of antigenemia on patients’ outcome Br J Haematol 1994 88: 64–71
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FA, Sanders JE, Stewart PS, Thomas ED . Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplantation from HLA-identical siblings Ann Intern Med 1983 98: 461–466
Henze G, Fengler R, Hartmann R, Kornhuber B, Janka Schaub G, Niethammer D, Riehm H . Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group Blood 1991 78: 1166–1172
Byar DP . Identification of prognostic factors. In: Buyse ME, Staquet MJ, Sylvester RJ (eds) Cancer Clinical Trial Methods in Practice Oxford Medical Publications: Oxford 1988 423–443
Clift R, Goldman JM, Gratwohl A, Horowitz M . A Proposal for standardized reporting of bone marrow transplantation for leukemia Bone Marrow Transplant 1989 4: 445–448
Kaplan EL, Meier P . Non parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481
Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R . Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods Br J Haematol 1993 83: 602–607
Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 1999 18: 695–706
Klein JP, Rizzo JD, Zhang M-J, Keiding N . Statistical methods for analisis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis Bone Marrow Transplant 2001 28: 909–915
Cox DR . Regression models and life tables J R Stat Soc 1972 34: 187–202
Klein JP, Rizzo JD, Zhang M-J, Keiding N . Statistical methods for analisis and presentation of the results of bone marrow transplants. Part 2: regression modeling Bone Marrow Transplant 2001 28: 1001–1011
Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A, Goulden P, Goulden NJ, Hale G, Waldmann H, Cornish JM . Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 1996 94: 574–578
Hongeng S, Krance RA, Bowman LC, Srivastava DK, Cunningham JM, Horwitz EM, Brenner MK, Heslop HE . Outcomes of transplantation with matched-sibling and unrelated donor bone marrow in children with leukemia Lancet 1997 350: 767–771
Saarinen-Pihkala UM, Gustafsson G, Ringden O, Heilmann C, Glomstein A, Lonnerholm G, Abrahamsson J, Bekassy AN, Schroeder H, Mellander L . No disadvantages in outcome of using matched unrelated donors as compared with matched sibling donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission J Clin Oncol 2001 19: 3406–3414
Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferriera E, Garnier F, Gluckman E . Factors associated with outcome after cord blood transplantation in children with acute leukemia Blood 1999 93: 3662–3671
Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E . Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukaemia Blood 2001 97: 2962–2971
Hamblin M, Marsh JC, Lawler M, McCann SR, Wickham N, Dunlop L, Ball S, Davies EG, Hale G, Waldmann H, Gordon-Smith EC . Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors Bone Marrow Transplant 1996 17: 819–824
Ringden O, Remberger M, Carlens S, Hagglund H, Mattsson J, Aschan J, Lonnqvist B, Klaesson S, Winiarski J, Dalianis T, Olerup O, Sparrelid E, Elmhorn-Rosenborg A, Svahn BM, Ljungman P . Low incidence of acute graft-versus-host disease using unrelated HLA-A, HLA-B, and HLA-DR-compatible donors and conditioning anti-T-cell antibodies Transplantation 1998 66: 620–625
Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, Di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N, van-Lint MT, Bosi A . Atithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 2001 98: 2942
Lawson SE, Harrison G, Richards S, Oakhill A, Stevens R, Eden OB, Darbyshire PJ . The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study Br J Haematol 2000 108: 531–543
Wheeler K, Richards S, Bailey C, Chessels JM . Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia. The MRC UKALL X experience Br J Haematol 1998 101: 94–103
Gaynon PS, Qu RP, Chappel RJ, Willoughby ML, Tubergen DG, Steinherz PG, Trigg ME . Survival after relapse in childhood acute lymphoblastic leukaemia: impact of time of first relapse, the Children's Cancer Group experience Cancer 1998 82: 1387–1395
Acknowledgements
This work has been partly supported by grants from AIRC (Associazione Italiana Ricerca sul Cancro), CNR (Consiglio Nazionale delle Ricerche), MURST (Ministero dell'Università e della Ricerca Scientifica e Tecnologica) and IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Policlinico S Matteo to FL. We are indebted to Geoff Hale for having kindly provided the monoclonal antibody Campath-1G.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Locatelli, F., Zecca, M., Messina, C. et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 16, 2228–2237 (2002). https://doi.org/10.1038/sj.leu.2402690
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402690
Keywords
This article is cited by
-
The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment
Seminars in Immunopathology (2021)
-
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia
Bone Marrow Transplantation (2019)
-
ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL
Bone Marrow Transplantation (2019)
-
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
Current Hematologic Malignancy Reports (2019)
-
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
Bone Marrow Transplantation (2015)